Related Experiment Videos
Effect of hydroxyethyl starch on platelet function following granulocyte collection using the continuous flow cell
Transfusion
|November 1, 1977
Summary
Hydroxyethyl starch (HES) infusion during granulocyte collection did not cause clinical bleeding. While platelet counts decreased slightly, they remained within normal limits, indicating HES is safe for platelet function.
Area of Science:
- Hematology
- Transfusion Medicine
Background:
- Hydroxyethyl starch (HES) is utilized as a sedimenting agent in blood component collection.
- Assessing the impact of HES on platelet parameters is crucial for donor safety.
Purpose of the Study:
- To evaluate the effect of 6% hydroxyethyl starch on platelet number and function in normal donors undergoing granulocyte collection.
Main Methods:
- Seventeen normal donors underwent granulocyte collection using a continuous flow cell separator (CFCS).
- Hydroxyethyl starch (500 ml of 6% solution) was administered as an adjunct.
- Platelet counts, adhesiveness, and aggregation (to ADP and collagen) were assessed pre- and post-collection.
Main Results:
- No clinical bleeding was observed in any donor.
- A mean 21% reduction in postcollection platelet count occurred, but all counts remained within normal limits.
- Platelet adhesiveness showed variable changes (increase, no change, or decrease).
- Platelet aggregation to ADP or collagen was largely unaffected, except in one donor.
Conclusions:
- The use of 500 ml of 6% hydroxyethyl starch as an adjunct for granulocyte separation via CFCS does not appear to adversely affect platelet number or function in normal donors.
- HES can be safely used in this context, with careful monitoring of platelet counts and function.